LWM
JUNO

Lenox Wealth Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Lenox Wealth Management’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100
Closed -$5K – 518
2017
Q4 		$5K Hold
100
– – ﹤0.01% 429
2017
Q3 		$4K Hold
100
– – ﹤0.01% 454
2017
Q2 		$3K Buy
+100
New +$2.47K ﹤0.01% 453

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Lenox Wealth Management's JUNO Position: Q1 2018 in Review

Lenox Wealth Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 100 shares — an estimated $5K sold.

Lenox Wealth Management first reported a position in JUNO in Q2 2017 and held it in 3 quarters. The position peaked at $5K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Lenox Wealth Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Lenox Wealth Management sold 100 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $5K.
  • Lenox Wealth Management first reported a position in Juno Therapeutics, Inc. in Q2 2017 and held it in 3 quarters.
  • Lenox Wealth Management's Juno Therapeutics, Inc. position peaked at $5K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Lenox Wealth Management's 13F filing for Q1 2018, filed 26 Apr 2018.